Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Plos One|April 21, 2023
Inhibition of the PCR by genomic DNASue Latham, Elizabeth Hughes, Bradley Budgen, et al.The Journal of Molecular Diagnostics : JMD|December 28, 2020
Patient-Specific Minimal Residual Disease Primers Amplify with Uniformly High EfficiencySusan Latham, Elizabeth Hughes, Bradley Budgen, et al.Plos One|October 4, 2017
Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemiaSue Latham, Elizabeth Hughes, Bradley Budgen, et al.Journal of Clinical Pathology|February 4, 2016
BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemiaSusan Latham, Paul A Bartley, Bradley Budgen, et al.The Journal of Molecular Diagnostics : JMD|January 3, 2015
A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemiaPaul A Bartley, Susan Latham, Bradley Budgen, et al.The Journal of Molecular Diagnostics : JMD|April 17, 2022
Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCRSue Latham, Elizabeth Hughes, Bradley Budgen, et al.The Journal of Molecular Diagnostics : JMD|March 28, 2009
Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukemiaAlexander A Morley, Sue Latham, Michael J Brisco, et al.The Journal of Molecular Diagnostics : JMD|March 28, 2009
Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemiaMichael J Brisco, Sue Latham, Rosemary Sutton, et al.Pageof 1